Amarin (AMRN) Gets USPTO Notice of Allowance for '150 App

September 10, 2012 8:31 AM EDT Send to a Friend
Amarin Corporation plc (Nasdaq: AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login